Quantcast

Latest Interventional cardiology Stories

2014-10-30 20:22:43

LONDON, Oct. 30, 2014 /PRNewswire/ -- This report studies the current as well as future prospects of the coronary stents market globally. The market for coronary stents is categorized into three major segments, namely, bare metal stents (BMS), drug eluting stents (DES) and bio-absorbable stents. Each of the market segments has been extensively analyzed on the basis of their commercial existence, efficacy, sales revenue and geographic presence. The market size and forecast in terms of...

2014-10-27 08:28:47

MALVERN, Pa., Oct. 27, 2014 /PRNewswire/ -- Essential Medical, Inc., a privately held medical device company, announced today that it has received CE mark approval for X-Seal(TM), a new vascular closure device with superior handling and closure features. X-Seal closes femoral arterial punctures made during cardiac catheterization procedures such as angiograms, angioplasty, and stenting. X-Seal is designed to provide Cath Lab professionals with superior closure and improved...

2014-10-21 23:12:01

Visit the Accreditation for Cardiovascular Excellence (ACE) Booth for Information on Quality Review Services WASHINGTON, DC (PRWEB) October 21, 2014 This week, ACE continues its role as a champion for cardiovascular quality by exhibiting at the Scripps Clinic’s 25th Annual Cardiovascular Interventions Meeting at the Hilton La Jolla Torrey Pines in La Jolla, CA, from October 21-24, 2014. Each year, the Cardiovascular Interventions meeting provides cardiologists, cardiac and vascular...

2014-10-20 23:05:56

Allegheny General Hospital, part of the Allegheny Health Network, is offering a new, minimally-invasive procedure that enables physicians to repair a damaged mitral valve as the heart continues to beat. The MitraClip system, developed by Abbott Vascular, is designed to treat degenerative mitral regurgitation (MR), a progressive and life-threatening condition in which the heart’s mitral valve leaflets fail to close tightly, allowing blood to flow backward from the heart’s left ventricle...

2014-10-20 23:04:44

MarketReportsOnline.com adds "Global LVAD Market Report: 2014 Edition" report to its research store. Dallas, Texas (PRWEB) October 20, 2014 LVAD, Left Ventricular Assist Device, is a mechanical device that circulates blood throughout the body when the heart is too weak to pump blood on its own. They are used in bridge-to-transplantation (BTT), destination therapy (DT) and bridge to recovery. With the existing conventional therapies and other invasive therapies that provide only...

2014-10-20 08:31:41

First Patient Enrolled in PLATINUM Diversity Trial Evaluating Performance in Women, Black Americans, Latinos/Hispanics, Native Americans and Alaska Natives with Coronary Artery Disease MARLBOROUGH, Mass., Oct. 20, 2014 /PRNewswire/ -- As part of its commitment to innovation and improving patient outcomes, Boston Scientific Corporation (NYSE: BSX) has initiated the PLATINUM Diversity trial to evaluate the clinical performance of the Promus PREMIER((TM)) Everolimus-Eluting Platinum...

2014-10-15 08:31:46

PLEASANTON, Calif., Oct. 15, 2014 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, today announced that it will report its operating results for the third quarter of fiscal year 2014 on Wednesday, November 5. The company will hold a conference call to discuss its financial results and operating activities, open to all interested parties, at 1:30 p.m., Pacific...

2014-10-09 23:12:40

Patient Enrollment Process to begin in Southern California for expanding indications of the NobleStitch EL™ Suture Closure of PFO “Patent Forman Ovale” and the repair of Iatrogenic ASD “Atrial Septal Defect”. FOUNTAIN VALLEY, CA (PRWEB) October 09, 2014 Nobles Medical Technologies II, Inc. (NMT2) today announced that it has begun the process to enroll patients for the US Clinical Study of its NobleStitch EL PFO Closure System. Earlier this year the first American patient to be...

2014-10-08 20:22:07

Comprehensive Clinical Data from Randomized Trials Reviewed MARLBOROUGH, Mass., Oct. 8, 2014 /PRNewswire/ -- After reviewing updated data and analysis for the Boston Scientific Corporation (NYSE: BSX) WATCHMAN(TM) Left Atrial Appendage Closure (LAAC) Device, the U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel of the Medical Devices Advisory Committee voted in favor of the Device. By a vote of 6 to 5 (with 1 abstention) the Panel concluded that the benefits of...

2014-10-08 12:28:07

"Recapturable" heart valve tested as alternative to open heart surgery ANN ARBOR, Mich., Oct. 8, 2014 /PRNewswire-USNewswire/ -- The University of Michigan Frankel Cardiovascular Center is one of the first hospitals in the country to implant Medtronic's new investigational device during transcatheter aortic valve replacement (TAVR). The CoreValve(®) Evolut((TM)) R System is being studied in patients with severe aortic stenosis who are considered at high or extreme risk for open...


Latest Interventional cardiology Reference Libraries

Coronary Angiography
2013-07-29 11:05:01

A coronary angiography, also known as a coronary catheterization, is a procedure that gives both visual and tactical access to coronary circulation and blood filled chambers of the heart for both diagnostic and interventional purposes. It is one of many diagnostic tests used in cardiology. More specifically, coronary catheterization recognizes occlusion, stenosis, thrombosis or aneurismal enlargement of the walls of the coronary arteries; heart chamber size; heart muscle contraction...

More Articles (1 articles) »
Word of the Day
barghest
  • A goblin in English folklore, often appearing in the shape of a large dog and believed to portend imminent death or misfortune.
  • A ghost, wraith, hobgoblin, elf, or spirit.
The origin of 'barghest' is not known, but it may be from perhaps burh-ghest, town-ghost, or German Berg-geist (mountain spirit) or Bär-geist (bear-spirit).
Related